A tyrosine

In order for the cyclooxygenase to function, a source of hydroperoxide (R—O—O—H) appears to be required. The hydroperoxide oxidizes a heme prosthetic group at the peroxidase active site of PGH synthase. This in turn leads to the oxidation of a tyrosine residue producing a tyrosine radical which is apparendy involved in the abstraction of the 13-pro-(5)-hydrogen of AA (25). The cyclooxygenase is inactivated during catalysis by the nonproductive breakdown of an active enzyme intermediate. This suicide inactivation occurs, on average, every 1400 catalytic turnovers. 

Figure 1 Schematic diagram depicting the partitioning of an enzymatic system into quantum and classical regions. The side chains of a tyrosine and valine are treated quantum mechanically, whereas the remainder of the enzyme and added solvent are treated with a classical force field.

Src tyrosine kinases comprise SH2 and SH3 domains in addition to a tyrosine kinase... 

Figure 13.30 Ribbon diagram of the structure of Src tyrosine kinase. The structure is divided in three units starting from the N-terminus an SH3 domain (green), an SH2 domain (blue), and a tyrosine kinase (orange) that is divided into two domains and has the same fold as the cyclin dependent kinase described in Chapter 6 (see Figure 6.16a). The linker region (red) between SH2 and the kinase is bound to SH3 in a polyproline helical conformation. A tyrosine residue in the carboxy tail of the kinase is phosphorylated and bound to SH2 in its phosphotyrosine-binding site. A disordered part of the activation segment in the kinase is dashed. (Adapted from W. Xu et al.. Nature 385 595-602, 1997.)...

Src tyrosine kinase contains both an SH2 and an SH3 domain linked to a tyrosine kinase unit with a structure similar to other protein kinases. The phosphorylated form of the kinase is inactivated by binding of a phosphoty-rosine in the C-terminal tail to its own SH2 domain. In addition the linker region between the SH2 domain and the kinase is bound in a polyproline II conformation to the SH3 domain. These interactions lock regions of the active site into a nonproductive conformation. Dephosphorylation or mutation of the C-terminal tyrosine abolishes this autoinactivation. 

Pt02 (stoichiometric), TEA, AcOH, H2, 91% yield. This method cannot be used in substrates that contain a tyrosine, because tyrosine is easily reduced in the acidic medium. Neutral conditions fail to cleave phenyl phosphates. ... 

In the case of a tyrosine auxotrophic mutant, the mutant does not produce at least one of the enzymes to synthesise tyrosine (E6 in Figure 8.4). 

The cDNA for this photoprotein has been cloned and expressed in E. coli, and the recombinant protein obtained was named mitrocomin (Fagan et al., 1993). Mitrocomin consists of 190 amino acid residues with a tyrosine residue at the C-terminus, and has three Ca2+-binding sites. 

Sorafenib is a multitargeted cancer therapy that inhibits VEGFR, PDGFR, KIT, fetal liver tyrosine kinase 3 (FLT-3), and the serine/threonine kinase RAF. RAF kinase is a key downstream effector of Ras in the MAPK/Ras signal-transduction pathway that has been linked to various cancers. Sorafenib is both a tyrosine kinase inhibitor and serine/threonine signal-transduction inhibitor. Sorafenib has been approved in renal cancer. 

I topoisomerase of mammals is a 100 kD monomeric protein whose activity is ATP-independent. This enzyme binds to double-stranded DNA and cleaves one of the DNA strands of the duplex, simultaneously forming an enzyme-DNA covalent bond between a tyrosine residue and the 3 -phosphate of the cleaved DNA. The type II topoisomerases are dimeric enzymes, which are ATP-dependant. Two isoforms of topoisomerase II exist, topoisomerase a and (3, with apparent molecular weights of 170 and 180 kD. Topoisomerase... 

An early step in Fak activation is a high stoichiometry autophosphorylation of a tyrosine residue (Y397)... 

The current understanding on activation of Tec kinases fits into a two-step model. In the first step an intramolecular interaction between the SH3 domain and aproline-rich region in the TH domain is disrupted by binding ofthe PH domain to phosphoinositides, G protein subunits, or the FERM domain of Fak. These interactions lead to conformational changes of Tec and translocation to the cytoplasmic membrane where, in a second step, Src kinases phosphorylate a conserved tyrosine residue in the catalytic domain thereby increasing Tec kinase activity. Autophosphorylation of a tyrosine residue in the SH3 domain further prevents the inhibitory intramolecular interaction resulting in a robust Tec kinase activation. 

In contrast to tyrosine kinases, Tyrosine phosphatases (PTPs) are enzymes which act on phosphorylated proteins and catalyze the transfer of a phosphate group from a tyrosine residue to a water molecule, generating orthophosphates in a process which is referred to as dephosphorylation. PTPs are involved in many cellular signal transduction pathways. 

The growth requirement for EGF is a good example in this regard. EGF stimulates the growth of many different types of animal cells in culture. In order to initiate the growth response, EGF interacts with specific EGF receptors localized in the plasma membrane, activating a tyrosine-specific protein kinase, which is an intrinsic part of the receptor (Figure 12). As a consequence, specific proteins are phosphorylated at tyrosine residues, and some of these proteins (which are also... 

In the Fepr protein the two clusters are some 12-13 A apart and probably within electron transfer range. However, as shown in Fig. 15, there are no obvious electron pathways involving the polypeptide chain. A tyrosine residue, Tyr 493, lies approximately midway be-... 

Fig. 15. The two Fe-S clusters are some 12-13 A apart and within possible electron transfer range. A tyrosine residue, Y493, is situated roughly halfway between the two clusters, but whether it plays a role in any electron transfer is unclear. Two adjacent tryptophan residues are also located close to cluster 2 again, their possible roles in any enzymatic reaction remain to be defined.

In order to account for the inability of many enzymes to bind the protonated form of the basic inhibitors or permanently cationic ones better than uncharged analogs (for example, yS-o-galactosidase from E. coli, and P-v>-glucosidase from almonds), it was proposed that the enzyme could proton-ate the inhibitor at the active site by a cationic acid (for example, protonated histidine). If proton transfer cannot occur, the attractive forces due to the carboxylate would be canceled by the repulsion from the cationic acid. Experimental evidence for this proposal is, however, still lacking. In fi-D-gn-lactosidase from E. coli, a tyrosine is presumed to be responsible for the protonation of substrates. ... 

A. Tyrosine Hydroxylase Is Rate-Limiting FOR Catecholamine Biosynthesis ... 

---